CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus

Journal of Immunology

Volumn 161, Issue 9, 1998, Pages 4583-4590

  Thomsen, A Randrup ^a,b   Nansen, A ^a   Christensen, J Pravsgaard ^a,c   Andreasen, S Ørding ^a   Marker, O ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN GP 39; IMMUNOGLOBULIN MU CHAIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL INTERACTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; KNOCKOUT MOUSE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CHRONIC DISEASE; FEMALE; IMMUNITY, NATURAL; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGIC MEMORY; IMMUNOLOGIC SURVEILLANCE; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES, CYTOTOXIC; VIRUS REPLICATION;

EID: 3643064537     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Klein, M. R., C. A. van Baalen, A. M. Holwerda, S. R. Kerkhof-Garde, R. J. Bende, I. P. M. Keet, J. K. M. Eeftinck-Schattenkerk, A. D. M. E. Osterhaus, H. Schuitemaker, and F. Miedema. 1995. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1365.
2. Ahmed, R., A. Salmi, L. D. Butler, J. M. Chiller, and M. B. Oldstone. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice: role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160:521.
3. Pfau, C. J., J. K. Valenti, D. C. Pevear, and K. D. Hunt. 1982. Lymphocytic choriomeningitis virus killer T cells are lethal only in weakly disseminated murine infections. J. Exp. Med. 156:79.
4. Moskophidis, D., M. Battegay, M. van den Broek, E. Laine, U. Hoffmann-Rohrer, and R. M. Zinkernagel. 1995. Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus. J. Gen. Virol. 76:381.
5. Moskophidis, D., F. Lechner, H. Pircher, and R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758.
6. + T-cell-deficient mice. J. Virol. 68:4700.
7. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056.
8. Thomsen, A. R., J. Johansen, O. Marker, and J. P. Christensen. 1996. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice. J. Immunol. 157:3074.
9. + T cells in cell-mediated immunity to LCMV: studies in MHC class I- and class II-deficient mice. Scand. J. Immunol. 40:373.
10. + T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 62:2102.
11. + T lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J. Virol. 61:1867.
12. Walsh, C. M., M. Matloubian, C. C. Liu, R. Ueda, C. G. Kurahara, J. L. Christensen, M. T. F. Huang, J. D. Young, R. Ahmed, and W. R. Clark. 1994. Immune function in mice lacking the perform gene. Proc. Natl. Acad. Sci. USA 91:10854.
13. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
14. + T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA 94:6874.
15. Noelle, R. J., J. A. Ledbetter, and A. Aruffo. 1992. CD40 and its ligand, an essential ligand-recepcor pair for thymus-dependent B-cell activation. Immunol. Today 13:431.
16. Xu, J., T. M. Foy, J. D. Laman, E. A. Elliott, J. J. Dunn, T. J. E. Waldschmidt, R. J. Noelle, and R. A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity 1:423.
17. Whitmire, J. K., M. K. Slifka, I. S. Grewal, R. A. Flavell, and R. Ahmed. 1996. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. J. Virol. 70:8375.
18. + T cell functions. J. Exp. Med. 183:2209.
19. + CTL response. J. Exp. Med. 183:2129.
20. + lymphocytes during an acute viral infection. J. Exp. Med. 169:2159.
21. Marker, O., and M. Volkert. 1973. Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice. J. Exp. Med. 137:1511.
22. + T cells facilitates homing to inflammatory sites. J. Immunol. 153:2021.
23. Marker, O., A. Scheynius, J. P. Christensen, and A. R. Thomsen. 1995. Virus-activated T cells regulate expression of adhesion molecules on endothelial cells in sites of infection. J. Neuroimmunol. 62:35.
24. Thomsen, A. R., and O. Marker. 1989. MHC and non-MHC genes regulate elimination of lymphocytic choriomeningitis virus and antiviral CTL and delayed-type hypersensitivity mediating T lymphocyte activity in parallel. J. Immunol. 142:1333.
25. Andersson, E. C., J. P. Christensen, O. Marker, and A. R. Thomsen. 1994. Changes in cell adhesion molecule expression on T cells associated with systemic virus infection. J. Immunol. 152:1237.
26. + T cells with a type 1 cytokine profile. Int. Immunol. 8:1453.
27. 4 integrin expression. Int. Immunol. 8:707.
28. + T cells. Scand. J. Immunol. 42:110.
29. Asano, M. S., and R. Ahmed. 1996. CD8 T cell memory in B cell-deficient mice. J. Exp. Med. 183:2165.
30. + T-cell responses. Immunol. Today 17:410.
31. Tian, L., R. J. Noelle, and D. A. Lawrence. 1995. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur. J. Immunol. 25:306.
32. Stout, R. D., J. Suttles, J. Xu, I. S. Grewal, and R. A. Flavell. 1996. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J. Immunol. 156:8.
33. Christensen, J. P., O. Marker, and A. R. Thomsen. 1994. Non-MHC genes influence virus clearance through regulation of the antiviral T-cell response: correlation between virus clearance and Tc and Td activity in segregating backcross progeny. Exp. Clin. Immunogenet. 11:33.
34. Eyler, Y. L., C. J. Pfau, K. S. Broomhall, and A. R. Thomsen. 1989. The combination of major histocompatibility complex (MHC) and non-MHC genes influences murine lymphocytic choriomeningitis virus pathogenesis. Scand. J. Immunol. 29:527.
35. + T cell clones can provide B cell help. J. Immunol. 154:3118.
36. + type 2 cytotoxic T cells restricts their potential B cell helper activity. Eur. J. Immunol. 27:914.
37. + T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyperIgE. J. Exp. Med. 181:423.
38. Hasbold, J., C. Johnson-Leger, C. J. Atkins, E. A. Clark, and G. G. Klaus. 1994. Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies. Eur. J. Immunol. 24:1835.
39. Ruby, J., H. Bluethmann, M. Aguet, and I. A. Ramshaw. 1995. CD40 ligand has potent antiviral activity. Nat. Med. 1:437.